Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹13.98.
30 Oct: open ₹14.29, high ₹14.29, low ₹13.30
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 10,91372.6% delivered
Vivo Bio Tech share news and announcements
594 announcements, routine notices left out, newest first. Page 5 of 12.
Sep 2022
7 Sep · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on September 6, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....6 Sep · Reg. 34 (1) Annual Report.
Aug 2022
Jul 2022
27 Jul · Board meeting
Meeting on 10 Aug 2022: quarterly results12 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
15 Jun · Related Party Transaction For The Half-Year Ended 31.03.2022
May 2022
19 May · Board meeting
Meeting on 30 May 2022: audited results6 May · Announcement under Regulation 30 (LODR)-Allotment
Apr 2022
22 Apr · Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022.
19 Apr · Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022.
11 Apr · Change In Authorisation Under Regulation 30 (5) Of SEBI (Listing Obligations And Requirements) Regulations, 2015
Feb 2022
28 Feb · Intimation Of Purchase Of Land & Building-Reg.
2 Feb · Results
2 Feb · Disclosure
Jan 2022
29 Jan · New Facility At Andhra Pradesh Med Tech Zone-Visakhapatnam
24 Jan · Board meeting
Meeting on 2 Feb 2022: quarterly results15 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....12 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Jan · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
8 Jan · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/511509 ....7 Jan · Results
Dec 2021
6 Dec · Meeting
2 Dec · Board meeting
Meeting on 2 Dec 20212 Dec · Board meeting
Nov 2021
2 Nov · Authorization Of KMP's Under Regulation 30(5) Of SEBI (LODR) Regulations,2015
2 Nov · Board meeting
Oct 2021
25 Oct · Board meeting
Meeting on 2 Nov 2021: quarterly results